bf/NASDAQ:GRCL_icon.jpeg

NASDAQ:GRCL

Gracell Biotechnologies Inc.

  • Stock

USD

Last Close

10.24

21/02 21:00

Market Cap

989.87M

Beta: −1.83

Volume Today

6.37M

Avg: 131.30K

PE Ratio

−12.25

PFCF: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
net income
-60.79M
-
-138.66M
128.09%
-211.90M
52.82%
-451.75M
113.19%
-607.51M
34.48%
depreciation and amortization
2.99M
-
5.12M
71.26%
21.59M
321.33%
60.27M
179.16%
77.51M
28.61%
deferred income tax
stock based compensation
60.38M
-
24.10M
60.09%
change in working capital
-4.05M
-
703K
117.34%
-10.75M
1,629.45%
25.26M
334.90%
15.08M
40.28%
accounts receivables
inventory
accounts payables
other working capital
other non cash items
-2.56M
-
2.91M
214.01%
1.30M
55.49%
8.17M
529.84%
net cash provided by operating activities
-61.86M
-
-135.39M
118.88%
-198.15M
46.35%
-304.55M
53.70%
-482.65M
58.48%
investments in property plant and equipment
-11.36M
-
-56.43M
396.89%
-79.40M
40.70%
-56.74M
28.54%
-48.39M
14.72%
acquisitions net
-97.80K
-
28.05M
28,786.09%
10M
64.36%
261.17M
2,511.66%
purchases of investments
-335M
-
-80.20M
76.06%
-28.05M
65.02%
-10M
64.36%
-261.17M
2,511.66%
sales maturities of investments
233M
-
178M
23.61%
13.51M
92.41%
25.13M
85.93%
261.22M
939.61%
other investing activites
97.80K
-
-28.05M
28,786.09%
-10M
64.36%
-261.17M
2,511.66%
net cash used for investing activites
-113.36M
-
41.37M
136.49%
-93.94M
327.09%
-41.62M
55.70%
-48.33M
16.14%
debt repayment
-10M
-
-138.82M
-
-51.29M
63.05%
-68.48M
33.50%
common stock issued
1.45B
-
common stock repurchased
-44.70M
-
dividends paid
other financing activites
148.69M
-
439.50M
195.57%
895.28M
103.70%
58.52M
93.46%
101.80M
73.96%
net cash used provided by financing activities
138.69M
-
394.80M
184.65%
756.47M
91.61%
1.46B
92.50%
33.32M
97.71%
effect of forex changes on cash
-603K
-
-22.13M
3,569.49%
-35.32M
59.63%
123.30M
449.07%
net change in cash
-36.52M
-
300.17M
921.97%
442.25M
47.33%
1.07B
143.01%
-374.36M
134.83%
cash at beginning of period
48.41M
-
11.89M
75.44%
312.06M
2,524.54%
754.31M
141.72%
1.83B
142.47%
cash at end of period
11.89M
-
312.06M
2,524.54%
754.31M
141.72%
1.83B
142.47%
1.45B
20.47%
operating cash flow
-61.86M
-
-135.39M
118.88%
-198.15M
46.35%
-304.55M
53.70%
-482.65M
58.48%
capital expenditure
-11.36M
-
-56.43M
396.89%
-79.40M
40.70%
-56.74M
28.54%
-48.39M
14.72%
free cash flow
-73.21M
-
-191.82M
162.01%
-277.55M
44.69%
-361.29M
30.17%
-531.04M
46.98%

All numbers in USD (except ratios and percentages)